ArticleJournal of investigative medicine high impact case reports

Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract.

Kok Hoe Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.